PEP Talks: The CMO's Leadership in Patient-Centric Innovation

Special guest: Dr. David Gillen, Chief Medical Officer, Norgine

In this episode of PEP Talks, Emma interviews Dr. David Gillen, discussing the evolution and importance of patient engagement in the pharmaceutical industry. Dr. Gillen emphasises the critical role of patient engagement professionals in drug development and acknowledges the challenges and benefits of integrating patient voices into clinical trials, regulatory frameworks, and medical affairs. The conversation also touches on the impact of social media and online communities in amplifying patient voices, the professionalisation of patient engagement, and the complexities of developing medicines for paediatric populations.